Home    >   Phospho Specific Antibodies

Anti-phospho-p53 (Ser392)

Rabbit Polyclonal Antibody
Catalog No. P05-363R




Catalog No. Pack Size Price (USD)
P05-363R-100 100 ul $715
P05-363R-BULK BULK Contact Us  


Overview:

p53 is a key regulator of cell growth and acts as a tumor suppressor gene. Wild-type p53 gene can suppress transformation of rat embryo fibroblasts in cell culture by other oncogenes such as the adenovirus E1A and Ras (1). DNA tumor viruses such as SV40 large T antigen and the adenovirus E1A plus E1B-55Kd proteins bind to p53 and inactivate its tumor suppressor activities leading to cellular transformation. Mutational inactivation of the p53 gene is detected in more than 50% of human cancers. Mutation of p53 renders cancer cells more resistant to current cancer therapies due to lack of p53-mediated apoptosis (2).

References:


1. Levine, A J. et al: Tumor suppressor genes: the p53 and retinoblastoma sensitivity genes and gene products. Biochim Biophys Acta. 1990 Jun 1;1032(1):119-36.

2. Sun, Y. p53 and its downstream proteins as molecular targets of cancer. Mol Carcinog. 2006 Jun;45(6):409-15.


Specificity:

Recognizes the p53 protein phosphorylated at serine 392


Cross Reactivity:

Human and Rat


Host:

Rabbit, IgG


Immunogen:

Synthetic phospho-peptide corresponding to amino acid residues surrounding Ser392 conjugated to KLH


Purification:

Affinity Chromatography


Stability:

Store at 4oC (add 0.1% NaN3) for several months, and at -20oC for longer periods. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles.


Sample Data:

Western blot of rat brain nuclear fraction lysate showing specific immunolabeling of the ~53kDa p53 phosphorylated at Ser392 (Control). The phosphospecificity of this labeling is shown in the second lane (lambda-phosphatase: lambda-Ptase). The blot is identical to the control except that it was incubated in lambda-Ptase (1200 units for 30 min) before being exposed to the Anti-phospho-p53 (Ser392) antibody. The immunolabeling is completely eliminated by treatment with lambda-Ptase.



Product Datasheets



RESEARCH AREAS

Apoptosis/Autophagy, Cancer, Cardiovascular Disease, Cell Cycle, Cellular Stress, Inflammation, JNK/SAPK Pathway, Metabolic Disorder, Neurobiology, p38 Pathway



SIGNALCHEM BIOTECH INC.


About

Terms of Service

Privacy Policy

Get the latest resources, updates and offers in your inbox